483
8046255 Canada Inc.8046255 Canada Inc. – FDA 483, Sep 24, 2019
Record Details
The FDA inspected 8046255 Canada Inc. DBA Viatrexx, a sterile injectable drug product manufacturer in Beloeil, from September 16-24, 2019. The inspection revealed significant deficiencies in aseptic processing, environmental monitoring, laboratory controls, and quality control record-keeping, indicating a severe lack of adherence to cGMP for sterile drug manufacturing. These issues raise serious concerns about the sterility and quality assurance of their injectable drug products.
View Company Profile
ID · 5a6e4438-346a-48c0-9674-280f370ec9c4
Other documents for 8046255 Canada Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.